Published in Appl Health Econ Health Policy on February 01, 2016
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax (2008) 4.79
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation (2010) 4.50
COPD in Japan: the Nippon COPD Epidemiology study. Respirology (2004) 2.81
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest (2010) 2.75
International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ (2010) 2.57
Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol (2014) 2.23
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Med Decis Making (2006) 2.09
Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke (2003) 2.05
The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis (1963) 1.83
Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med (2012) 1.70
Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav (1999) 1.68
Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med (2006) 1.59
Late relapse/sustained abstinence among former smokers: a longitudinal study. Prev Med (2004) 1.40
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction (2012) 1.32
Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation. Cost Eff Resour Alloc (2008) 1.13
Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study. Addiction (2009) 1.12
Predictors of lapse and relapse to smoking in successful quitters in a varenicline post hoc analysis in Japanese smokers. Clin Ther (2014) 0.88
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan. Pharmacoeconomics (2009) 0.84
A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value Health (2010) 0.83
Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry). Int J Cardiol (2011) 0.83
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions. Pharmacoeconomics (2013) 0.80
Web-based survey on smoking cessation behaviors of current and former smokers in Japan. Curr Med Res Opin (2014) 0.78
Medical care for chronic-phase stroke in Japan. Neurol Med Chir (Tokyo) (2012) 0.77
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data. Pharmacoeconomics (2011) 0.77